New Japanese Regulatory Frameworks for Clinical Research and Marketing Authorization of Gene Therapy and Cellular Therapy Products-Reference-Cited by-同舟云学术

New Japanese Regulatory Frameworks for Clinical Research and Marketing Authorization of Gene Therapy and Cellular Therapy Products

Published:2017-07-06 Issue:1 Volume:17 Page:
ISSN:1566-5232
Container-title:Current Gene Therapy
language:en
Short-container-title:CGT

Author:

Nagai Sumimasa¹,Ozawa Keiya²

Affiliation:

1. Division of Genetic Therapeutics, The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 4-6-1, Shirokanedai, Minato- ku, Tokyo 1088639, Japan

2. Division of Genetic Therapeutics, The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Publisher

Bentham Science Publishers Ltd.

Subject

Genetics (clinical),Drug Discovery,Genetics,Molecular Biology,Molecular Medicine

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biosafety and regulatory issues of RNA therapeutics;Progress in Molecular Biology and Translational Science;2024

2. Global regulatory progress in delivering on the promise of gene therapies for unmet medical needs;Molecular Therapy - Methods & Clinical Development;2021-06

3. Therapeutic Use of Mesenchymal Stromal Cells: The Need for Inclusive Characterization Guidelines to Accommodate All Tissue Sources and Species;Frontiers in Cell and Developmental Biology;2021-02-16

4. Enhancing Matured Stem-Cardiac Cell Generation and Transplantation: A Novel Strategy for Heart Failure Therapy;Journal of Cardiovascular Translational Research;2020-11-30

5. Regulatory oversight of cell therapy in China: Government’s efforts in patient access and therapeutic innovation;Pharmacological Research;2020-08